WHO. The Community Health Worker: Working Guide, Guidelines for Training, Guidelines for Adaption. Geneva: WHO, 1987
12.
MachadoPA. The Brazilian program for schistosomiasis control 1975–1979. Am J Trop Med Hyg1982; 31: 76–86
13.
KloetzelKSchusterNH. Repeated mass treatment of Schistosomiasis mansoni, even when reinfection is expected. Trans R Soc Trop Med Hyg1987; 81: 365–70
14.
ChandiwanaSKTaylorP. The rational use of antischistosomal drugs in schistosomiasis control. Soc Sci Med1990; 30: 1131–8
15.
El KhobyTGalalNFenwickA. The USAID government of Egypt's schistosomiasis research project (SRP). Parasitology Today1998; 14: 92–6
16.
WebbeGEl HakS. Progress in the control of schistosomiasis in Egypt 1985–1988. Trans R Soc Trop Med Hyg1990; 84: 394–400
17.
JordanP. Schistosomiasis in Tanganyika, observations on suppressive management of Schistosoma haematobium with TWSb with particular reference to reduction in ova load. Trans R Soc Trop Med Hyg1962; 56: 523–8
18.
JordanP. Schistosomiasis: The St Lucia Project. Cambridge: Cambridge University Press, 1985: 1–442
19.
GryseelsBNkulikyinkaLEngelsD. Repeated community-based chemotherapy for the control of Schistosoma mansoni – effect of screening and selective treatment on prevalence and intensities of infection. Am J Trop Med Hyg1991; 45: 509–17
20.
SavioliLDixonHKisumkuUMMottKE. Control of morbidity due to Schistosoma haematobium on Pemba Island: selective population chemotherapy of school children with haematuria to identify high risk localities. Trans R Soc Trop Med Hyg1989; 83: 805–10
21.
WarrenKSMahmoudAAF. Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Phys1976; 89: 195–204
22.
OumaJHWijersDJBSiongokTK. ARAP The effect of repeated targeted mass treatment on the prevalence of Schistosomiasis mansoni and the intensity of infection in Machakos, Kenya. Ann Trop Med Parasit1985; 79: 431–8
23.
SavioliLHatzCDixonHKisumkuUMMottKE. Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and haematuria as indicators of infection. Am J Trop Med Hyg1990; 43: 289–95
24.
WilkinsHA. Reinfection after treatment of schistosome infections. Parasitology Today1989; 5: 83–3
25.
ButterworthAECapronMCordingleyJSDaltonPRDunneDWKariukiHC, Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg1985; 79: 393–408
26.
ButterworthAEHaganP. Immunity to schistosomiasis. Parasitology Today1987; 3: 11–16
27.
GangChen Ming. Schistosoma japonicum and S. japonicum-like infections: epidemiology, clinical and pathological aspects. In: JordanPWebbeGSturrockRF, eds Human Schistosomiasis. Wallingford: CAB International, 1993; 237–70
28.
PicquetMVercruysseJShawDJDiopMAbdoulayeLy. Efficacy of praziquantel against Schistosoma mansoni in Northern Senegal. Trans R Soc Med Hyg1998; 92: 90–3